Driehaus Capital Management LLC Celldex Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $5.99 Million - $10.9 Million	-292,292 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $6.17 Million - $8.78 Million	-223,197 Reduced 43.3%	292,292 $9.96 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $1.27 Million - $2 Million	-35,576 Reduced 6.46%	515,489 $19.9 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $991,421 - $1.92 Million	-34,246 Reduced 5.85%	551,065 $29.8 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $4.9 Million - $8.36 Million	236,471 Added 67.79%	585,311 $19.6 Million
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $718,431 - $1.33 Million	-44,375 Reduced 11.29%	348,840 $7.19 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $128,134 - $194,467	-8,548 Reduced 2.13%	393,215 $6.89 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $3.88 Million - $6.1 Million	401,763 New	401,763 $5.96 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.